Cardlytics, Inc. Logo

Cardlytics, Inc.

CDLX

(0.5)
Stock Price

3,88 USD

-179.31% ROA

-55.65% ROE

-0.7x PER

Market Cap.

280.666.815,00 USD

116.39% DER

0% Yield

-36.85% NPM

Cardlytics, Inc. Stock Analysis

Cardlytics, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cardlytics, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's PBV ratio (1.14x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

2 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

3 ROE

Negative ROE (-99.24%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-147.44%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 DER

The stock is burdened with a heavy load of debt (111%), making it financially unstable and potentially risky for investors.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-16) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Cardlytics, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cardlytics, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Sell
4 Stoch RSI Sell

Cardlytics, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cardlytics, Inc. Revenue
Year Revenue Growth
2015 77.634.000
2016 112.821.000 31.19%
2017 130.365.000 13.46%
2018 150.684.000 13.48%
2019 210.430.000 28.39%
2020 186.892.000 -12.59%
2021 267.116.000 30.03%
2022 298.542.000 10.53%
2023 316.020.000 5.53%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cardlytics, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2015 11.604.000
2016 13.902.000 16.53%
2017 12.150.000 -14.42%
2018 16.210.000 25.05%
2019 11.699.000 -38.56%
2020 17.532.000 33.27%
2021 38.104.000 53.99%
2022 54.435.000 30%
2023 49.720.000 -9.48%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cardlytics, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2015 18.197.000
2016 21.355.000 14.79%
2017 20.100.000 -6.24%
2018 34.228.000 41.28%
2019 36.720.000 6.79%
2020 46.532.000 21.09%
2021 66.222.000 29.73%
2022 81.446.000 18.69%
2023 62.244.000 -30.85%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cardlytics, Inc. EBITDA
Year EBITDA Growth
2015 -38.359.000
2016 -173.000 -22072.83%
2017 -13.490.000 98.72%
2018 -30.875.000 56.31%
2019 -12.790.000 -141.4%
2020 -42.331.000 69.79%
2021 -61.199.000 30.83%
2022 -91.798.000 33.33%
2023 -19.540.000 -369.8%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cardlytics, Inc. Gross Profit
Year Gross Profit Growth
2015 25.140.000
2016 40.409.000 37.79%
2017 50.106.000 19.35%
2018 54.681.000 8.37%
2019 79.457.000 31.18%
2020 63.274.000 -25.58%
2021 103.340.000 38.77%
2022 112.632.000 8.25%
2023 143.396.000 21.45%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cardlytics, Inc. Net Profit
Year Net Profit Growth
2015 -40.625.000
2016 -75.696.000 46.33%
2017 -19.641.000 -285.4%
2018 -53.042.000 62.97%
2019 -17.692.000 -199.81%
2020 -58.470.000 69.74%
2021 -128.565.000 54.52%
2022 -465.264.000 72.37%
2023 -95.864.000 -385.34%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cardlytics, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2015 -3
2016 -5 60%
2017 -1 -400%
2018 -3 50%
2019 -1 0%
2020 -2 100%
2021 -4 33.33%
2022 -14 76.92%
2023 -3 -550%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cardlytics, Inc. Free Cashflow
Year Free Cashflow Growth
2015 -35.459.000
2016 -35.043.000 -1.19%
2017 -23.749.000 -47.56%
2018 -26.337.000 9.83%
2019 437.000 6126.77%
2020 -17.715.000 102.47%
2021 -51.087.000 65.32%
2022 -67.390.000 24.19%
2023 -1.952.000 -3352.36%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cardlytics, Inc. Operating Cashflow
Year Operating Cashflow Growth
2015 -29.158.000
2016 -32.498.000 10.28%
2017 -22.102.000 -47.04%
2018 -18.995.000 -16.36%
2019 11.457.000 265.79%
2020 -7.598.000 250.79%
2021 -38.523.000 80.28%
2022 -53.904.000 28.53%
2023 1.194.000 4614.57%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cardlytics, Inc. Capital Expenditure
Year Capital Expenditure Growth
2015 6.301.000
2016 2.545.000 -147.58%
2017 1.647.000 -54.52%
2018 7.342.000 77.57%
2019 11.020.000 33.38%
2020 10.117.000 -8.93%
2021 12.564.000 19.48%
2022 13.486.000 6.84%
2023 3.146.000 -328.67%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cardlytics, Inc. Equity
Year Equity Growth
2015 -162.161.000
2016 -216.835.000 25.21%
2017 -208.686.000 -3.9%
2018 51.975.000 501.51%
2019 143.267.000 63.72%
2020 157.192.000 8.86%
2021 690.700.000 77.24%
2022 211.605.000 -226.41%
2023 225.335.000 6.09%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cardlytics, Inc. Assets
Year Assets Growth
2015 82.290.000
2016 86.859.000 5.26%
2017 100.758.000 13.79%
2018 153.763.000 34.47%
2019 224.313.000 31.45%
2020 422.537.000 46.91%
2021 1.263.797.000 66.57%
2022 691.236.000 -82.83%
2023 634.916.000 -8.87%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cardlytics, Inc. Liabilities
Year Liabilities Growth
2015 244.451.000
2016 303.694.000 19.51%
2017 309.444.000 1.86%
2018 101.788.000 -204.01%
2019 81.046.000 -25.59%
2020 265.345.000 69.46%
2021 573.097.000 53.7%
2022 479.631.000 -19.49%
2023 409.581.000 -17.1%

Cardlytics, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
8.06
Net Income per Share
-10.17
Price to Earning Ratio
-0.7x
Price To Sales Ratio
0.92x
POCF Ratio
-16.74
PFCF Ratio
-10
Price to Book Ratio
1.21
EV to Sales
1.48
EV Over EBITDA
-7.42
EV to Operating CashFlow
-27.92
EV to FreeCashFlow
-16.13
Earnings Yield
-1.42
FreeCashFlow Yield
-0.1
Market Cap
0,28 Bil.
Enterprise Value
0,45 Bil.
Graham Number
36.85
Graham NetNet
-6.27

Income Statement Metrics

Net Income per Share
-10.17
Income Quality
0.04
ROE
-1.71
Return On Assets
-0.2
Return On Capital Employed
-0.22
Net Income per EBT
1
EBT Per Ebit
1.33
Ebit per Revenue
-0.28
Effective Tax Rate
-1.48

Margins

Sales, General, & Administrative to Revenue
0.24
Research & Developement to Revenue
0.18
Stock Based Compensation to Revenue
0.14
Gross Profit Margin
0.43
Operating Profit Margin
-0.28
Pretax Profit Margin
-0.37
Net Profit Margin
-0.37

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.43
Free CashFlow per Share
-0.74
Capex to Operating CashFlow
0.73
Capex to Revenue
-0.04
Capex to Depreciation
-0.38
Return on Invested Capital
-0.25
Return on Tangible Assets
-1.79
Days Sales Outstanding
128.99
Days Payables Outstanding
7.05
Days of Inventory on Hand
0.15
Receivables Turnover
2.83
Payables Turnover
51.77
Inventory Turnover
2467.41
Capex per Share
-0.31

Balance Sheet

Cash per Share
2,37
Book Value per Share
5,93
Tangible Book Value per Share
-5.11
Shareholders Equity per Share
5.93
Interest Debt per Share
7.02
Debt to Equity
1.16
Debt to Assets
0.41
Net Debt to EBITDA
-2.82
Current Ratio
1.15
Tangible Asset Value
-0,19 Bil.
Net Current Asset Value
-0,20 Bil.
Invested Capital
1.16
Working Capital
0,03 Bil.
Intangibles to Total Assets
0.66
Average Receivables
0,10 Bil.
Average Payables
0,00 Bil.
Average Inventory
74500
Debt to Market Cap
0.93

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cardlytics, Inc. Dividends
Year Dividends Growth

Cardlytics, Inc. Profile

About Cardlytics, Inc.

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

CEO
Mr. Karim Temsamani
Employee
434
Address
675 Ponce de Leon Avenue NE
Atlanta, 30308

Cardlytics, Inc. Executives & BODs

Cardlytics, Inc. Executives & BODs
# Name Age
1 Mr. Nick Lynton
Chief Legal & Privacy Officer and Secretary
70
2 Ms. Evelyne Forester
Chief Business Officer
70
3 Mr. Karim Temsamani
Chief Executive Officer & Director
70
4 Ms. Alexis DeSieno
Chief Financial Officer
70
5 Mr. Amit Gupta
Chief Operating Officer & GM of Bridg
70
6 Mr. Peter Chan
Chief Technology Officer
70
7 Mr. Peter Davies
Head of Sales Strategy & Operations
70
8 Ms. Carson Napps
Head of People
70
9 Mr. Jose Singer
Chief Product Officer
70

Cardlytics, Inc. Competitors